Skip to content

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

Stryker Customized Plates for Mandibular Reconstruction: A Retrospective Post Market Follow Up to Confirm Safety and Performance of Surgeon iD Mandible Reconstruction Plates

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07221916
Acronym
SMRP
Enrollment
70
Registered
2025-10-28
Start date
2024-12-01
Completion date
2026-02-27
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandible Fracture, Mandibular Reconstruction

Brief summary

A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Detailed description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Surgeon iD Mandible Recon Plate when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. Based on a non-inferiority study power calculation a minimum of 27 patients will be enrolled in the study. Additional patients may be enrolled up to 80 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States and one in the EU will participate in this study. The primary outcome parameter evaluating successful reconstruction of the mandible without the need for unplanned revision surgery will be assessed at all available follow-up timepoints for included patients.

Interventions

Mandibular Reconstruction or mandibular fracture fixation using a Surgeon iD Mandible Reconstruction Plate (referred to as Surgeon iD Plates).

Sponsors

Stryker Craniomaxillofacial
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients who underwent primary or secondary mandibular reconstruction using a Stryker Surgeon iD Plate implant as per routine clinical practice. 2. Patients for whom data on the primary outcome variable is available.

Exclusion criteria

1. Patients with active local infections at the time of surgery. 2. Patients with known metal allergies and/or foreign body sensitivity at the time of surgery. 3. Potentially non-compliant patients who were unwilling or incapable of following post-operative care instructions. 4. Patients with inadequate bone quantity or quality necessary for plate fixation or stabilization at the time of surgery

Design outcomes

Primary

MeasureTime frameDescription
Rate of successful reconstruction of the mandible without the need for unplanned revision surgery compared to benchmark devices in scientific literature.Data collected at a single time point per patient in the course of 12 monthsRate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.

Secondary

MeasureTime frameDescription
Infection rateData collected at time points from patient medical charts in the course of 12 months.Determined by adverse events reported from patient medical charts.
Intraoperative complicationsData collected at a single time point per patient in the course of 12 months.Determined by adverse events reported from patient medical charts.
Postoperative complicationsData collected at time points per patient in the course of 12 months.Determined by adverse events reported from patient medical charts.
Any known adverse eventsData collected at time points per patient in the course of 12 months.Determined by adverse events reported from patient medical charts.
Rate of Plate failureData collected at time points per patient in the course of 12 months.Determined by adverse events reported from patient medical charts.
Operating room (OR) timeData collected at a single time point per patient in the course of 12 months.Time patients are operated (hh:mm)
Time to return to solid food/normal dietData collected at a single time point per patient in the course of 12 months.Time for patient to return to solid food/normal diet post operation (dd)
Rate of satisfactory occlusion achieved with orthodontic treatment.Data collected at time points per patient in the course of 12 months.Assessed by review of individual patient medical records that document the rate of satisfactory occlusion achieved with orthodontic treatment.
Hospitalization time: ICU and normal wardData collected at a single time point per patient in the course of 12 months.Time the patient was hospitalized post procedure (dd:hh)
Short-form-12-health-survey-questionnaire (if available)Data collected at time points per patient in the course of 12 months.Short-form-12-health-survey-Questionnaire (Scale of 0-100. Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health).
Ischemia timeData collected at a single time point per patient in the course of 12 months.Ischemia time (dd:hh)
EuroQol-5 Domain Questionnaire (if available)Data collected at time points per patient in the course of 12 months.A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).
Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)Data collected at time points per patient in the course of 12 months.40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

Countries

Germany, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026